Flex and Merck KGaA, Darmstadt, Germany, Win 2025 PDA Drug Delivery Innovation Award

Core Insights - Flex's Health Solutions business received the 2025 PDA Drug Delivery Innovation Award for its collaboration with Merck KGaA on a connected autoinjector [1][2] - The award highlights the importance of digital health solutions in improving patient outcomes, particularly in chronic disease management [2][4] - The collaboration has been ongoing for nearly two decades, focusing on patient-centric drug delivery solutions that enhance therapy adherence and patient experience [3] Company Collaboration - The connected autoinjector integrates a smart injection device, a cloud-based data system, a mobile app for patients, and a monitoring dashboard for healthcare professionals [4] - This solution allows for automated injection, real-time data sharing, personalized settings, and intuitive interfaces, improving treatment efficiency and outcomes for both patients and providers [4][5] - The partnership exemplifies the effectiveness of long-term collaboration and technical excellence in driving innovation within the healthcare sector [5] Company Overview - Flex operates as a global manufacturing partner, providing advanced manufacturing and supply chain solutions across 30 countries [6] - The company focuses on innovative products and technology, supporting customers from concept to scale, particularly in the AI era [6]